Effect of protease inhibitors on the sense of taste

Nutrition

Volumn 15, Issue 10, 1999, Pages 767-772

  Schiffman, Susan S ^a   Zervakis, Jennifer ^a   Heffron, Sean ^a   Heald, Alison E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bitter; Human immunodeficiency virus (HIV); Protease inhibitors; Taste; Thresholds

Indexed keywords

AMIDE; CALCIUM CHLORIDE; CAPSAICIN; CITRIC ACID; FERROUS SULFATE; INDINAVIR; NELFINAVIR; POTASSIUM CHLORIDE; PROTEINASE INHIBITOR; QUININE; RITONAVIR; SAQUINAVIR; SODIUM CHLORIDE; SUCROSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TASTE; TASTE ACUITY;

ADULT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; NELFINAVIR; RITONAVIR; SAQUINAVIR; TASTE; TASTE DISORDERS;

CINCHONA PUBESCENS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032822036     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(99)00152-5     Document Type: Article

References (32)

1. Carpenter C.C.J., Fischl M.A., Hammer S.M., et al. Antiretroviral therapy for HIV infection in 1998 updated recommendations of the International AIDS Society-USA panel . JAMA. 280:1998;78.
2. Centers for Disease Control. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR. 47:1998;43.
3. Hammer S.M., Squires K.E., Hughes M.D., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 337:1997;725.
4. Cameron D.W., Heath-Chiozzi M., Danner S., et al. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet. 351:1998;543.
5. Moore R, Keruly JC, Gallant J, Chaisson RE. Decline in mortality rates and opportunistic disease in combination antiretroviral therapy. 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland, Abstract 22374.
6. Egger M., Hirschel B., Francioli P., et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland prospective multicentre study. Swiss HIV Cohort Study . Br Med J. 315:1997;1194.
7. Chodakewitz JA, Leavitt R, Massari F, et al. Indinavir: summary of 24-week experience with Indinavir at 2.4 g/d in phase II trials. XI International Conference on AIDS, July 7-12, 1996, Vancouver, British Columbia, Canada.
8. Physicians' desk reference, 51st edition. 1997;Medical Economics Company, Montvale.
9. Stone VE, Hirschhorn LR, Boswell SL. Discontinuation of protease inhibitor therapy: reasons and risk factors. 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland, Abstract 12443.
10. Melvin A.J., Mohan K.M., Arcuino L.A., Edelstein R.E., Frenkel L.M. Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Ped Infect Dis J. 16:1997;968.
11. Gross E, Burr CK, Storm D, Czarniecki L, D'Orlando D. Monitoring treatment adherence in pediatric HIV; identifying the issues from providers and families. 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland, Abstract 32428.
12. Kunches L, Mazzullo JM, Miller-Mack E, Russell M, Ortega JSI. Educational and support needs of people living with HIV to improve adherence to highly active antiretroviral therapy. 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland, Abstract 32333.
13. Heald A.E., Pieper C.F., Schiffman S.S. Taste and smell complaints in HIV-infected patients. AIDS. 12:1998;1667.
14. Gilbertson T.A. The physiology of vertebrate taste reception. Curr Opinion Neurobiol. 3:1993;532.
15. Kinnamon S.C., Cummings T.A. Chemosensory transduction mechanisms in taste. Annu Rev Physiol. 54:1992;715.
16. Margolskee R.F. The biochemistry and molecular biology of taste transduction. Curr Opinion Neurobiol. 3:1993;526.
17. Mucklow J.C., Bending M.R., Kahn G.C., Dollery C.T. Drug concentrations in saliva. Clin Pharmacol Ther. 24:1978;563.
18. Kragh-Sorensen P., Larsen N.E. Factors influencing nortriptyline steady state kinetics plasma and saliva levels . Clin Pharmacol Ther. 28:1980;796.
19. Paxton J.W., Donald R.A. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum. Clin Pharmacol Ther. 28:1980;695.
20. Levy G., Procknal J.A., Olufs R., Pachman L.M. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis. Clin Pharmacol Ther. 27:1980;619.
21. + salts and sweeteners. Proc Nat Acad Sci. 80:1983;6136.
22. Schiffman S.S., Gill J.M., Diaz C. Methyl xanthines enhance taste evidence for modulation of taste by adenosine receptor . Pharmacol Biochem Behav. 22:1985;195.
23. Schiffman S.S., Simon S.A., Gill J.M., Beeker T.G. Bretylium tosylate enhances salt taste. Physiol Behav. 36:1986;1129.
24. Schiffman S.S., Gatlin L.A., Frey A.E., et al. Taste perception of bitter compounds in young and elderly persons relation to lipophilicity of bitter compounds . Neurobiol Aging. 15:1994;743.
25. Dalakas M.C., Cupler E.J. Neuropathies in HIV infection. Baillieres Clin Neurol. 5:1996;199.
26. Gray F., Scaravilli F., Everall I., et al. Neuropathology of early HIV-1 infection. Brain Pathol. 6:1996;1.
27. Moatti M., Aubin F., Charlot V., Ades J. Anxiety and depression within a population suffering from AIDS comparison with a mixed population affected by malignant hemopathy ( . abstract no. M.B.2062). Int Conf AIDS. 7:1991;197.
28. Dess N.K., Edelheit D. The bitter with the sweet the taste/stress/temperament nexus . Biol Psychol. 48:1998;103.
29. Dess N.K., Chapman C.D. Individual differences in taste, body weight, and depression in the "helplessness" rat model and in humans. Brain Res Bull. 24:1990;669.
30. Hoetelmans R.M., van Essenberg M., Meenhorst P.L., Mulder J.W., Beijnen J.H. Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 698:1997;235.
31. Hoetelmans R.M., van Essenberg M., Profijt M., et al. High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva. J Chromatogr B Biomed Sci Appl. 705:1998;119.
32. Dahl M., Erickson R.P., Simon S.A. Neural responses to bitter compounds in rats. Brain Res. 756:1997;22.